Target intelligence / Profile preview

Caudate nucleus inhibitory neurons

Molecular classification
Cell population, GABAergic neurons
01

Overview

Caudate nucleus inhibitory neurons are a specialized population of cells within the basal ganglia, predominantly consisting of GABAergic medium spiny neurons (MSNs) and various classes of inhibitory interneurons (StatPearls, 'Neuroanatomy, Caudate Nucleus'). These neurons serve as the primary input layer of the striatum, integrating excitatory signals from the cerebral cortex and thalamus to regulate motor activity, learning, and executive function (NCBI, 'The Basal Ganglia'). In diseases like Huntington's, the selective degeneration of these inhibitory neurons leads to disinhibition of the motor thalamus, resulting in involuntary movements and cognitive deficits (PubMed, PMID: 21304554). While the neurons themselves are a cellular population rather than a single molecular target, they express a high density of therapeutic targets including dopamine D1 and D2 receptors, adenosine A2A receptors, and GABA receptors. Pharmacological intervention typically aims to modulate the activity of these neurons to restore balance within the direct and indirect pathways of the basal ganglia (Nature Reviews Neuroscience, 'Basal ganglia: circuits and functions').

Other names
Striatal GABAergic neuronsMedium spiny neurons of the caudateCaudate MSNsGABAergic interneurons of the caudate nucleus
02

Mechanism of action

Modulation of GABAergic signaling and dopaminergic/glutamatergic inputs to regulate the activity of the basal ganglia direct and indirect pathways.

03

Biological functions

Inhibitory neurotransmissionMotor controlHabit formationGoal-directed behaviorReward processing
04

Disease associations

Huntington's diseaseParkinson's diseaseObsessive-compulsive disorderTourette syndromeSchizophrenia
05

Safety considerations

Extrapyramidal symptomsTardive dyskinesiaNeuroleptic malignant syndromeMotor fluctuationsCognitive impairment
06

Interacting drugs

Haloperidol

4 more in the full profile.

07

Biomarkers

Striatal volume (via MRI)Dopamine transporter (DAT) density (via SPECT/PET)GABA concentration (via Magnetic Resonance Spectroscopy)Neurofilament light chain (NfL) in CSF/plasma

Beyond the preview

Go deeper on Caudate nucleus inhibitory neurons.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caudate nucleus inhibitory neurons.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call